Cardiovalve Transfemoral System - FIM Study

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 12, 2017

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2026

Conditions
Mitral Regurgitation
Interventions
DEVICE

Cardiovalve transfemoral Mitral valve system

Cardiovalve System, comprised of: 1) Cardiovalve Implant; 2) Cardiovalve Delivery System (DS); 3) Cardiovalve Accessories.

Trial Locations (1)

Unknown

RECRUITING

Hospital of the Lithuanian University of Health Sciences ligoninė Kauno, Kaunas

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Meditrial Europe Ltd.

INDUSTRY

lead

Cardiovalve Ltd.

INDUSTRY

NCT03958773 - Cardiovalve Transfemoral System - FIM Study | Biotech Hunter | Biotech Hunter